Erbito, Kimberly .
HRN: 23-12-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2023
CEFUROXIME 500MG (TAB)
06/05/2023
06/12/2023
PO
500mg
BID For 7 Days
S/p NSVD With RMLE
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes